Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus-Reference-Cited by-同舟云学术

Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus

Published:1998-05 Issue:3 Volume:13 Page:522-528
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Pranzatelli Michael R.,Huang Yung-Yu,Tate Elizabeth,Goldstein David S.,Holmes Courtney S.,Goldstein Edward M.,Ketner Karen,Kinast Morris,Lange Bernadette M.,Sanz Alfred,Shevell Michael I.,Stanford Richard E.,Taff Ingrid P.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference17 articles.

1. The neurobiology of opsoclonus-myoclonus;Pranzatelli;Clin Neuropharmacol,1992

2. On the molecular mechanism of adrenocorticotrophic hormone: neurotransmitters and receptors;Pranzatelli;Exp Neurol,1994

3. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in pediatric opsoclonus-myoclonus;Pranzatelli;Ann Neurol,1995

4. Serotonin and human myoclonus: rationale for the use of serotonin receptor agonists and antagonists;Pranzatelli;Arch Neurol,1994

5. The immunopharmacology of the opsoclonusmyoclonus syndrome;Pranzatelli;Clin Neuropharmacol,1996

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid biomarkers in neurological diseases in children;European Journal of Paediatric Neurology;2013-01

2. Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome;Journal of Child Neurology;2012-02-28

3. Management of patients with myoclonus: available therapies and the need for an evidence-based approach;The Lancet Neurology;2010-10

4. Pediatric Dosing of Rituximab Revisited: Serum Concentrations in Opsoclonus-myoclonus Syndrome;Journal of Pediatric Hematology/Oncology;2010-07

5. B cell depletion therapy for new-onset opsoclonus-myoclonus;Movement Disorders;2010-01-08